There are 2867 resources available
425P - Novel CoupledCAR technology for treating colorectal cancer
Presenter: Jiuwei Cui
Session: Poster session 08
426P - Assessing nivolumab in class II expressing microsatellite stable (pMMR) colorectal cancer (CRC): Results of the ANICCA-Class II trial
Presenter: Gary Middleton
Session: Poster session 08
427P - Targeting adenosine (ADO) to improve the efficacy of combinations of cetuximab (CET) and immunotherapy in EGFRvIII MSS colorectal cancer (CRC)
Presenter: Min Shi
Session: Poster session 08
428P - Tyrosine kinase inhibitor (TKI) plus PD-1 blockade in TKI-responsive MSS/pMMR metastatic colorectal adenocarcinoma (mCRC): Preliminary results of TRAP study
Presenter: Jingdong Zhang
Session: Poster session 08
429P - Management of localized anal cancer and prognostic factors in the elderly: Results of the French multicenter cohort FFCD – ANABASE
Presenter: Claire GOURIOU
Session: Poster session 08
430P - Prediction of pathologic complete response to preoperative (chemo)radiotherapy and/or chemotherapy in rectal cancer using clinical and imaging parameters
Presenter: Masoud Karimi
Session: Poster session 08
431P - Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16
Presenter: Sara Bastian
Session: Poster session 08
432P - Determinants of pre-surgical treatment in primary rectal cancer: A population-based study
Presenter: Israa Imam
Session: Poster session 08
433P - Pre-treatment and post-treatment MRI extramural venous invasion, predicts disease-free survival and overall survival, in locally advanced rectal cancer
Presenter: Laia Fernández Mañas
Session: Poster session 08
434P - Cetuximab in combination with 5 FU plus irinotecan based chemotherapy in metastatic squamous cell anal carcinoma: A single center experience
Presenter: Marine Valery
Session: Poster session 08